glp 1 eye disease GLP-1 Drugs and Ocular Disease: Between Neuroprotection and Risk Diabetes Weight Loss Drugs May

A 2025 pulse survey by the International Foundation of Employee Benefit Plans found most Canadian employers now cover GLP1s for diabetes, but coverage for weightloss indications is far less common and usually comes with conditions such as prior authorization, BMI thresholds and step therapy

LCACs also affect Ca 2+ homeostasis between the mitochondria and the ER

For those who have struggled with plateaus on existing medications, or who face multiple interconnected health issues, this kind of therapy may offer a more complete solution

Some estimates show that every cell in your body takes 10,000 oxidative hits to its DNA daily

We know this from everyday life

Should you ask your doctor about switching GLP-1s